RFWA
GILD icon

RPg Family Wealth Advisory’s Gilead Sciences GILD Stock Holding History

RPg Family Wealth Advisory’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-247
Closed -$17.7K – 296
2016
Q4 		$17.7K Buy
+247
New +$18.4K 0.02% 201
2016
Q2 		– Sell
-499
Closed -$45.8K – 266
2016
Q1 		$45.8K Sell
499
-111
-18% -$10K 0.04% 133
2015
Q4 		$61.7K Buy
+610
New +$63.5K 0.06% 85

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

RPg Family Wealth Advisory's GILD Position: Q1 2017 in Review

RPg Family Wealth Advisory sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 247 shares — an estimated $17.7K sold.

RPg Family Wealth Advisory first reported a position in GILD in Q4 2015 and held it in 3 quarters. The position peaked at $61.7K in Q4 2015. 1,525 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • RPg Family Wealth Advisory reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • RPg Family Wealth Advisory sold 247 Gilead Sciences shares in Q1 2017, an estimated $17.7K.
  • RPg Family Wealth Advisory first reported a position in Gilead Sciences in Q4 2015 and held it in 3 quarters.
  • RPg Family Wealth Advisory's Gilead Sciences position peaked at $61.7K in Q4 2015.
  • 1,525 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on RPg Family Wealth Advisory's 13F filing for Q1 2017, filed 12 May 2017.